CombiMatrix Prepares Cancer Array for Launch, Inks Sales and Marketing Deal with Clarient

Called the DNAarray Oligo 180K Heme Profile, the new test contains "thorough coverage of all the key oncogenes and cancer-related chromosomal regions" endorsed by the Cancer Cytogenomics Microarray Consortium.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.